Brain metastases (BM) are the most common intracranial neoplasm in adults. Initially
considered as an essentially terminal stage of advanced cancer, BM are increasingly being …

Objective This study sought to assess clinical outcomes in patients receiving gamma knife
radiosurgery (GK) for treatment of brain metastases from melanoma and evaluate for …

Patients with melanoma brain metastases (MBM) still have a very poor prognosis. Several
treatment modalities have been investigated in an attempt to improve the management of …

The prognosis for patients with melanoma who have brain metastases is poor, a median
survival does not exceed 4–6 months. There are no uniform standards of treatment for …

Opinion statement Malignant melanoma with brain metastases remains a difficult disease to
treat. Patients presenting with disease affecting the central nervous system (CNS) have a …

Currently, survival of breast cancer patients with brain metastasis ranges from 2 to 16
months. In experimental brain metastasis studies, only 10% of lesions with the highest …

Backgroud Brain metastases are the most common malignant intracranial tumors, however,
the prognosis of patients is still poor despite multiple treatment have been applicated. The …

Background The development of brain metastases is common in patients with melanoma
and is associated with a poor prognosis. Treating patients with melanoma brain metastases …

Relapses in the brain remain a major obstacle to cure in many patients with advanced
melanoma. At present, the management of melanoma brain metastases continues to rely …

Introduction. Melanoma gives rise to 7–13% brain metastases (MBM—melanoma brain
metastases) and is ranked third leading cause of brain metastases. The prognosis of …